OCUGEN, INC. Other Current Assets
OCUGEN, INC. (OCGN) had Other Current Assets of $849.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:OtherAssetsCurrent · last filed 2026-08-06
- 2026-06-30: Other Assets, Current $849.00K.
- 2026-03-31: Other Assets, Current $756.00K.
- 2025-12-31: Other Assets, Current $439.00K.
- 2024-12-31: Other Assets, Current $879.00K.
| Period end | Other Assets, Current | Other Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $849.00K 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $756.00K 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $439.00K 10-Q · filed 2026-08-06 | |
| 2024-12-31 | $879.00K 10-K · filed 2026-03-04 | |
| 2018-12-31 | $172.00K 10-K · filed 2019-03-22 | |
| 2017-12-31 | $122.00K 10-K · filed 2019-03-22 | $112.00K 10-K · filed 2018-03-15 |
| 2016-12-31 | $68.00K 10-K · filed 2018-03-15 | |
| 2015-12-31 | $195.00K 10-K · filed 2017-03-16 | |
| 2014-12-31 | $146.00K 10-K · filed 2016-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B |